Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Alcon Ord Shs ALC

Alcon AG is a Switzerland-based eye care company. The Company research, develop, manufacture, distribute and sell a full suite of eye care products within two key businesses: Surgical and Vision Care. The Company’s Surgical business is focused on ophthalmic products for cataract surgery, vitreoretinal surgery, refractive laser surgery and glaucoma surgery. The surgical portfolio includes... see more

Recent & Breaking News (NYSE:ALC)

Alcon Completes Acquisition of Aerie Pharmaceuticals, Inc., Strengthening Company's Ophthalmic Pharmaceutical Business

Business Wire November 22, 2022

Alcon Reports Third Quarter 2022 Results

Business Wire November 15, 2022

Alcon to Celebrate 75 Years of Brilliance and Showcase Contact Lens Innovations at #Academy22

Business Wire October 26, 2022

Alcon Completes Availability of Clareon Portfolio with Clareon Toric During AAO 2022

Business Wire September 29, 2022

AERIE PHARMACEUTICALS - INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Aerie Pharmaceuticals, Inc. - AERI

PR Newswire September 27, 2022

SHAREHOLDER ALERT: Weiss Law Investigates Aerie Pharmaceuticals, Inc.

PR Newswire August 23, 2022

Alcon to Acquire Aerie Pharmaceuticals, Inc., Enhancing its Ophthalmic Pharmaceutical Portfolio

Business Wire August 22, 2022

Alcon Reports Second Quarter 2022 Results

Business Wire August 9, 2022

Football Star Cooper Kupp Encourages Eye Allergy Sufferers to Find the Right Tool for the Job with Pataday

Business Wire June 6, 2022

Alcon Prices EUR 500.0 Million Senior Notes Offering

Business Wire May 24, 2022

Alcon to Acquire EYSUVIS Adding to Its Ophthalmic Eye Drop Portfolio

Business Wire May 23, 2022

Alcon Reports First Quarter 2022 Results

Business Wire May 10, 2022

Alcon Announces Results of 2022 Annual General Meeting

Business Wire April 27, 2022

Alcon's SMARTCataract Demonstrates Enhanced Efficiency and Time Savings for Cataract Surgeries

Business Wire April 23, 2022

Alcon to Deliver Robust Scientific Program at ASCRS 2022

Business Wire April 20, 2022

Actress Kate Walsh Teams Up with Eye Care Leader Alcon to Inspire Millions of Dry Eye Sufferers to Make Every Look Count

Business Wire April 7, 2022

Alcon Publishes Agenda for 2022 Annual General Meeting

Business Wire March 24, 2022

Alcon Strengthens Leadership in IOL Innovation with Launch of Clareon Portfolio in the U.S.

Business Wire March 7, 2022

Alcon Reports Fourth Quarter and Full Year 2021 Results

Business Wire February 15, 2022

Alcon Announces Launch of Systane Complete Preservative-Free Lubricant Eye Drops in Europe

Business Wire January 12, 2022